Haematology 7: Myelodysplastic Syndrome Flashcards
What are the haematological features of Myelodysplastic syndrome ?
Cytopaenias
Qualitative abnormalities of erythrocytes, myelocytes and megakaryocytes maturation
increased risk of transformation into leukaemia
Name the characteristic bilobed neutrophil seen in MDS ?
Pseudo Pelger-huet anomaly
List some abnormal cells seen with microscopy in MDS ?
Pseudo Pelger huet neutrophils (bilobed)
Dysgranulosis of neutrophils
Dyserythropoiesis of red cells
Ringed sideroblasts - iron granules visible
Micro megakaryocytes ( dysplastic megakaryocytes)
Increased proportion of blast cells in marrow
Myeloblasts with auer rods (also feature of AML)
Which disease does MDS often progress to ?
AML
Which drug can be used to treat MDS 5q- syndrome ?
Lenalidomide
List 3 Primary causes of bone marrow failure ?
Fanconi’s anaemia
Diamond blackfan anaemia
Kostmann’s syndrome
Acquired: idiopathic aplastic anaemia
Which 2 antibiotics can cause bone marrow failure ?
Chloramphenicol
Sulphonamide
How is fanconi anaemia inherited ?
Mainly autosomal recessive but some are X linked
List 4 congenital abnormalities seen in children with Fanconi anaemia ?
Absent radii
Abnormal thumbs
Cafe au lait spots
Short stature
What is the pathognomonic triad of clinical signs of Dyskeratosis Congenital (DC)?
Skin pigmentation
Nail dystrophy
Leukoplakia
These children look very old! The disease causes premature aging
What is the genetic cause of Dyskeratosis congenita ?
Mutation in Genes that encode proteins involved in maintenance of telomerases. These telomerases get shortened at the ends. This causes premature ageing
define myelodysplastic syndrome
biologically heterogeneous group of acquired haematopoietic stem cell disorders
characterised by development of a clone of marrow stem cells with abnormal maturation resulting in:
- functionally defective blood cells
- numerical reduction
usually elderly
develops over weeks/months
prognosis of patients with MDS
1/3 die from infection
1/3 die from bleeding
1/3 die from acute leukaemia
treatment options for MDS
allogenic stem cell transplant
intensive chemotherapy
supportive - blood products, antimicrobial, growth factors
biological modifiers - immunosuppressive agents, azacytidine, decitabine, lanalidomide
oral chemotherapy - hydroxyurea/hydroxycarbamide
low dose chemo - subcutaneous low-dose cytarabine
intensive chemo/stem cell transplant - for high risk MDS - AML-type regimes
secondary causes of bone marrow failure
marrow infiltration haematological malignancies (leukaemias, lymphomas) non-haematological (solid tumours) radiation drugs chemicals (eg benzene) AI infection (parovirus, viral hepatitis)